Article info
Clinical science
RAP study, report 1: novel subtype of macular neovascularisation type III, cilioretinal MNV3
- Correspondence to Professor Ursula Margarethe Schmidt-Erfurth, Department of Opththalmology, Medical University Vienna, Vienna 1090, Austria; ursula.schmidt-erfurth{at}meduniwien.ac.at
Citation
RAP study, report 1: novel subtype of macular neovascularisation type III, cilioretinal MNV3
Publication history
- Received November 14, 2019
- Revised February 12, 2020
- Accepted February 20, 2020
- First published March 11, 2020.
Online issue publication
December 11, 2020
Article Versions
- Previous version (11 March 2020).
- Previous version (7 April 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.